US equities |
SPCX $168.85 ▲+6.22% NVDA $237.96 ▲+1.71% MU $1,065.25 ▼-0.90% TSLA $380.38 ▲+2.64% MSFT $525.29 ▲+1.50% SNDK $1,716.10 ▼-0.23% INTC $117.10 ▼-1.87% META $745.12 ▲+2.34%
FinancialContent

Aytu BioPharma, Inc. - Common Stock (NQ:AYTU)

2.100 +0.030 (+1.45%)
Delayed Quote Updated: 1:37 PM EDT, Oct 5, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aytu BioPharma, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Keep an eye on the top gainers and losers in Wednesday's session. ↗
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report. 
Via Chartmill
News headline image
Gapping stocks in Wednesday's session ↗
The market is buzzing with gapping stocks on Wednesday. Let's uncover which stocks are experiencing notable gaps during today's session. 
Via Chartmill
News headline image
Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
Earnings Outlook For Aytu BioPharma ↗
 
Via Benzinga
News headline image
Aytu BioPharma Announces At the Market Pricing of $14.4 Million Upsized Public Offering of Common Stock
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
What's going on in today's after hours session ↗
The US market regular session of Tuesday is over, let's have a look at the top gainers and losers in the after hours session today. 
Via Chartmill
News headline image
Aytu BioPharma Inc (NASDAQ:AYTU) Shares Fall on Q4 Revenue and EPS Miss ↗
Aytu BioPharma shares fell after Q4 2025 results missed revenue and EPS estimates. The company remains focused on the upcoming launch of its depression drug, EXXUA, as a key growth catalyst. 
Via Chartmill
News headline image
Aytu BioPharma Reports Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results and Outlines Commercial Launch Plans for EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma's Q4 2025 Earnings: Anticipation Mounts Ahead of Key EXXUA Launch
NEW YORK, NY – September 23, 2025 – As the trading day concludes, all eyes in the biopharmaceutical sector are turning to Aytu BioPharma (NASDAQ: AYTU), which is poised to release its fiscal... 
Via MarketMinute
Topics Earnings
Dow Futures Gain Ahead Of Jerome Powell’s Speech: BA, HOLO, BETR, CLSK Among Stocks To Watch ↗
Via Stocktwits
Topics Economy Stocks
News headline image
Earnings Scheduled For September 23, 2025 ↗
 
Via Benzinga
News headline image
Aytu BioPharma to Report Fiscal 2025 Full Year and Fourth Quarter Operational and Financial Results on September 23, 2025
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
This Starbucks Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday ↗
 
Via Benzinga
News headline image
Aytu BioPharma Appoints Dr. Gerwin Westfield as Senior Vice President of Scientific Affairs to Support Commercialization of EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma Expands and Extends Lending Agreement with Eclipse Following Agreement to Commercialize First-in-Class Antidepressant EXXUA(TM)
Via ACCESS Newswire
News headline image
Aytu BioPharma Announces Closing of Upsized At the Market Public Offering of Common Stock with Full Exercise of Overallotment and Conference Call to Discuss First-in-Class Antidepressant EXXUA(TM) Opportunity and Commercialization Plan
Via ACCESS Newswire
News headline image
Which stocks are moving on Friday? ↗
Let's have a look at what is happening on the US markets one hour before the close of the markets on Friday. Below you can find the top gainers and losers in today's session. 
Via Chartmill
News headline image
Aytu BioPharma Announces Exclusive Agreement with Fabre-Kramer Pharmaceuticals to Commercialize First-in-Class Antidepressant EXXUA(TM) (gepirone) Extended-Release Tablets in the United States
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
These stocks have an unusual volume in today's session ↗
On Friday, there are stocks with unusual volume. Let's take a look. 
Via Chartmill
News headline image
Top movers in Friday's pre-market session ↗
As we await the opening of the US market on Friday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
Here are the top movers in Thursday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
These stocks are gapping in today's session ↗
Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
Via Chartmill
News headline image
Top movers in Thursday's pre-market session ↗
The US market session of Thursday has yet to be opened, let's have a look at the top gainers and losers in the pre-market session today. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >